Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction

Trautmann, Lydie, Janbazian, Loury, Chomont, Nicolas, Said, Elias A, Gimmig, Sylvain, Bessette, Benoit, Boulassel, Mohamed-Rachid, Delwart, Eric +5 more·2006·Nature Medicine
DOI 10.1038/nm1482

Cited by (1,001)

Items 501–600 of 1,001

  1. Proliferation Capacity and Cytotoxic Activity Are Mediated by Functionally and Phenotypically Distinct Virus-Specific CD8 T Cells Defined by Interleukin-7Rα (CD127) and Perforin Expression
    Cristina Cellerai, Matthieu Perreau, Virginie Rozot, Felicitas Bellutti Enders, Giuseppe Pantaleo, Alexandre Harari · 2010 · Journal of Virology
  2. Sprouty-2 regulates HIV-specific T cell polyfunctionality
    Yen‐Ling Chiu, Liang Shan, Hailiang Huang, Carl Haupt, Catherine Ami Bessell, David H. Canaday, Hao Zhang, Ya‐Chi Ho, Jonathan D. Powell, Mathias Oelke et al. · 2013 · Journal of Clinical Investigation
  3. Envelope-specific antibodies and antibody-derived molecules for treating and curing HIV infection
    Guido Ferrari, Barton F. Haynes, Scott Koenig, Jeffrey L. Nordstrom, David M. Margolis, Georgia D. Tomaras · 2016 · Nature Reviews Drug Discovery
  4. Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma
    Xiaomeng Dai, Jun Xue, Jianli Hu, Shengli Yang, George Y. Chen, Paul B.S. Lai, Chao Yu, Cui Zeng, Xiefan Fang, Xiaoli Pan et al. · 2017 · Translational Oncology
  5. Immune Checkpoints in Viral Infections
    Huiming Cai, Ge Liu, Jianfeng Zhong, Kai Zheng, Haitao Xiao, Chenyang Li, Xun Song, Ying Li, Chenshu Xu, Haiqiang Wu et al. · 2020 · Viruses
  6. Dynamic decrease in PD-1 expression correlates with HBV-specific memory CD8 T-cell development in acute self-limited hepatitis B patients
    Zheng Zhang, Bo Jin, Ji‐Yuan Zhang, Bin Xu, Huifen Wang, Ming Shi, E. John Wherry, George K.K. Lau, Fusheng Wang · 2009 · Journal of Hepatology
  7. Immune Control of HIV
    Muthukumar Balasubramaniam, Jui Pandhare, Chandravanu Dash · 2019 · JoLS Journal of Life Sciences
  8. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
    Rebar N. Mohammed, Rozita Tamjidifar, H. Rahman, A. Adili, S. Ghoreishizadeh, H. Saeedi, Lakshmi Thangavelu, N. Shomali, Ramin Aslaminabad, F. Marofi et al. · 2022 · Cell Communication and Signaling
  9. Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy
    Mohammad Tarique, Huma Naz, Mohd Suhail, Ali Turan, Chaman Saini, Naoshad Muhammad, Hari Shankar, Torki A. Zughaibi, Tabish Hasan Khan, Neena Khanna et al. · 2023 · Frontiers in Immunology
  10. PD-1 and Tim-3 Pathways Regulate CD8+ T Cells Function in Atherosclerosis
    Mingke Qiu, Songcun Wang, Yuxin Dai, Shuqing Wang, Jingmin Ou, Zhiwei Quan · 2015 · PLoS ONE
  11. Loss of DNAM‐1 contributes to CD8+ T‐cell exhaustion in chronic HIV‐1 infection
    Marina Cella, Rachel M. Presti, William Vermi, Kerry J. Lavender, Emma L. Turnbull, Christina Ochsenbauer‐Jambor, John C. Kappes, Guido Ferrari, Lisa Kessels, Ian G. Williams et al. · 2010 · European Journal of Immunology
  12. PD-1-Dependent Mechanisms Maintain Peripheral Tolerance of Donor-Reactive CD8+ T Cells to Transplanted Tissue
    Brent H. Koehn, Mandy L. Ford, Ivana R. Ferrer, Keshawna Borom, Shivaprakash Gangappa, Allan D. Kirk, Christian P. Larsen · 2008 · The Journal of Immunology
  13. Varicella zoster virus productively infects human peripheral blood mononuclear cells to modulate expression of immunoinhibitory proteins and blocking PD-L1 enhances virus-specific CD8+ T cell effector function
    Dallas Jones, Christina N. Como, Lichen Jing, Anna M. Blackmon, Charles Preston Neff, Owen Krueger, Andrew N. Bubak, Brent E. Palmer, David M. Koelle, Maria A. Nagel · 2019 · PLoS Pathogens
  14. Engineering CAR T Cells to Target the HIV Reservoir
    Wenli Mu, Mayra A. Carrillo, Scott G. Kitchen · 2020 · Frontiers in Cellular and Infection Microbiology
  15. IL-10: Achieving Balance During Persistent Viral Infection
    Cherie Tracy Ng, Michael B. A. Oldstone · 2014 · Current topics in microbiology and immunology
  16. Lymphocytic Alveolitis Is Associated with the Accumulation of Functionally Impaired HIV-Specific T Cells in the Lung of Antiretroviral Therapy–Naive Subjects
    Charles Preston Neff, Jennifer L. Chain, Samantha MaWhinney, Arlan D. Martin, Derek J. Linderman, Sonia C. Flores, Thomas Campbell, Brent E. Palmer, Andrew P. Fontenot · 2014 · American Journal of Respiratory and Critical Care Medicine
  17. Checkpoint Inhibition and Infectious Diseases: A Good Thing?
    Michael S. Abers, Michail S. Lionakis, Dimitrios P. Kontoyiannis · 2019 · Trends in Molecular Medicine
  18. Phenotypic and functional profiling of malaria-induced CD8 and CD4 T cells during blood-stage infection with Plasmodium yoelii
    Anmol Chandele, Paushali Mukerjee, Gobardhan Das, Rafi Ahmed, Virander S. Chauhan · 2010 · Immunology
  19. Clinical development of monoclonal antibody-based drugs in HIV and HCV diseases
    Michela Flego, Alessandro Ascione, Maurizio Cianfriglia, Stefano Vella · 2013 · BMC Medicine
  20. Myeloid-Derived Suppressor Cells in Murine Retrovirus-Induced AIDS Inhibit T- and B-Cell ResponsesIn VitroThat Are Used To Define the Immunodeficiency
    Kathy A. Green, W. James Cook, William R. Green · 2012 · Journal of Virology
  21. Immunodeficiency lentiviral infections in natural and non-natural hosts
    Jason M. Brenchley, Mirko Paiardini · 2011 · Blood
  22. Programmed death (PD)-1 molecule and its ligand PD-L1 distribution among memory CD4 and CD8 T cell subsets in human immunodeficiency virus-1-infected individuals
    Guglielmo Rosignoli, Chang Hyun Lim, Mark Bower, F Gotch, Nesrina Imami · 2009 · Clinical & Experimental Immunology
  23. Blocking of PDL-1 Interaction Enhances Primary and Secondary CD8 T Cell Response to Herpes Simplex Virus-1 Infection
    Rudragouda Channappanavar, Brandon S. Twardy, Susmit Suvas · 2012 · PLoS ONE
  24. B and T Lymphocyte Attenuator Tempers Early Infection Immunity
    Sun, Yonglian, Brown, Nicholas K, Ruddy, Matthew J, Miller, Mendy L, Lee, Youjin, Wang, Yang, Murphy, Kenneth M, Pfeffer, Klaus, Chen, Lieping, Kaye, Jonathan et al. · 2009 · The Journal of Immunology
  25. A novel cancer vaccine with the ability to simultaneously produce anti-PD-1 antibody and GM-CSF in cancer cells and enhance Th1-biased antitumor immunity
    Hongwei Tian, Gang Shi, Qin Wang, Yiming Li, Qianmei Yang, Chunlei Li, Guoyou Yang, Min Wu, Qian Xie, Shuang Zhang et al. · 2016 · Signal Transduction and Targeted Therapy
  26. FOXO3 Regulates the CD8 T Cell Response to a Chronic Viral Infection
    Jeremy A. Sullivan, Eui Ho Kim, Erin Hemmila Plisch, M. Suresh · 2012 · Journal of Virology
  27. PD-L2 modulates asthma severity by directly decreasing dendritic cell IL-12 production
    Ian Paul Lewkowich, Stéphane Lajoie, Sara L. Stoffers, Yuzo Suzuki, Phoebe K. Richgels, Krista M. Dienger, Alyssa A. Sproles, Hideo Yagita∥, Qutayba A. Hamid, Marsha A. Wills-Karp · 2012 · Mucosal Immunology
  28. Tumor immune surveillance and ovarian cancer
    Lana Elias Kandalaft, Gregory T. Motz, Jaikumar Duraiswamy, George Coukos · 2011 · Cancer and Metastasis Reviews
  29. Variable Patterns of Programmed Death-1 Expression on Fully Functional Memory T Cells after Spontaneous Resolution of Hepatitis C Virus Infection
    David Geoffrey Bowen, Naglaa H. Shoukry, Arash Grakoui, Michael John Fuller, Andrew G. Cawthon, Christine Dong, Dana L. Hasselschwert, Kathleen M. Brasky, Gordon James Freeman, Nilufer P. Seth et al. · 2008 · Journal of Virology
  30. PD-1 has a unique capacity to inhibit allergen-specific human CD4+ T cell responses
    Sandra Rosskopf, Beatrice Jahn‐Schmid, Klaus G. Schmetterer, Gerhard J. Zlabinger, Peter Steinberger · 2018 · Scientific Reports
  31. Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load
    Alessandra Marcia da Fonseca-Martins, Tadeu Diniz Ramos, Juliana Elena Silveira Pratti, Luan Firmino-Cruz, Daniel Cláudio Oliveira Gomes, Lynn Soong, Elvira M. Saraiva, Herbert Leonel de Matos Guedes · 2019 · Scientific Reports
  32. Use of Mass Cytometry to Profile Human T Cell Exhaustion
    Frances Winkler, Bertram Bengsch · 2020 · Frontiers in Immunology
  33. Interleukin-15 but Not Interleukin-7 Abrogates Vaccine-Induced Decrease in Virus Level in Simian Immunodeficiency Virusmac251-Infected Macaques
    Anna Hryniewicz, David A. Price, Marcin Moniuszko, Adriano Boasso, Yvette Edghill Spano, Sadie M. West, David J. Venzon, Monica Vaccari, Wen-Po Tsai, Elżbieta Anna Tryniszewska et al. · 2007 · The Journal of Immunology
  34. Programmed Cell Death 1-Directed Immunotherapy for Enhancing T-Cell Function
    Koichi Araki, Ben Youngblood, Rafi Ahmed · 2013 · Cold Spring Harbor Symposia on Quantitative Biology
  35. Immunobiology of Cancer Therapies Targeting CD137 and B7-H1/PD-1 Cosignal Pathways
    Shengdian Wang, Lieping Chen · 2010 · Current topics in microbiology and immunology
  36. Peptide Vaccine Induces Enhanced Tumor Growth Associated with Apoptosis Induction in CD8+ T Cells
    Daisuke Muraoka, Takuma Kato, Linan Wang, Yuka Maeda, Takuro Noguchi, Naozumi Harada, Kazuyoshi Takeda, Hideo Yagita∥, Philippe Guillaume, Immanuel F. Luescher et al. · 2010 · The Journal of Immunology
  37. HIV-1 Infection Is Associated with Depletion and Functional Impairment of Mycobacterium tuberculosis–Specific CD4 T Cells in Individuals with Latent Tuberculosis Infection
    Cheryl L. Day, Deborah Ann Abrahams, Levelle D. Harris, Michele van Rooyen, Lynnett Stone, Marwou de Kock, Willem Albert Hanekom · 2017 · The Journal of Immunology
  38. The Systemic Activation of Programmed Death 1-PD-L1 Axis Protects Systemic Lupus Erythematosus Model from Nephritis
    Wenjun Liao, Hua Zheng, Sha Wu, Yanmei Zhang, Wei Wang, Zili Zhang, Chenfei Zhou, Hongjun Wu, Jie Min · 2017 · American Journal of Nephrology
  39. Exhaustion of the CD8+ T Cell Compartment in Patients with Mutations in Phosphoinositide 3-Kinase Delta
    M. Wentink, Yvonne M. Mueller, V. Dalm, G. Driessen, P. V. van Hagen, J. V. van Montfrans, M. van der Burg, P. Katsikis · 2018 · Frontiers in Immunology
  40. A LAG-3–Specific Agonist Antibody for the Treatment of T Cell–Induced Autoimmune Diseases
    Mathieu Angin, Chrystelle Brignone, Frédéric Triebel · 2020 · The Journal of Immunology
  41. Immune checkpoint inhibitors and the liver: balancing therapeutic benefit and adverse events
    Eléonora De Martin, Claudia Angela Maria Fulgenzi, Ciro Celsa, Astrid Laurent-Bellue, Aria Torkpour, Pasquale Lombardi, Antonio D’Alessio, David James Pinato · 2024 · Gut
  42. Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection
    Hye-Young Jeong, Youn-Jae Lee, Su‐Kil Seo, Soo-Woong Lee, Sung Jae Park, Jeong-Nyeo Lee, Hae‐Sook Sohn, Sheng Yao, Lieping Chen, Inhak Choi · 2007 · Journal of Leukocyte Biology
  43. HIV-1 functional cure: will the dream come true?
    Chao Liu, Xiancai Ma, Bingfeng Liu, Cancan Chen, Hui Zhang · 2015 · BMC Medicine
  44. Sustained IFN-I Expression during Established Persistent Viral Infection: A “Bad Seed” for Protective Immunity
    Xavier Dagenais-Lussier, Hamza Loucif, Armstrong Murira, Xavier Laulhé, Simona Stäger, Alain Lamarre, Julien van Grevenynghe · 2017 · Viruses
  45. Expression of PD-1 and Tim-3 markers of T-cell exhaustion is associated with CD4 dynamics during the course of untreated and treated HIV infection
    Norma Ibón Rallón, Marcial García, Javier García‐Samaniego, Alfonso Cabello, Beatriz Álvarez, Clara Restrepo, Sara Nistal, Miguel Górgolas, Jose Miguel Benito · 2018 · PLoS ONE
  46. T cell toxicity of HIV latency reversing agents
    Manzhi Zhao, Elisa De Crignis, Casper Rokx, Annelies Verbon, Teun van Gelder, Tokameh Mahmoudi, Peter D. Katsikis, Yvonne M. Mueller · 2018 · Pharmacological Research
  47. Interleukin-10 contributes to reservoir establishment and persistence in SIV-infected macaques treated with antiretroviral therapy
    Justin L. Harper, Susan Pereira Ribeiro, Chi Ngai Chan, Malika Aïd, Claire Deléage, Luca Micci, María Pino, Barbara Cervasi, Gopalan Raghunathan, Eric Rimmer et al. · 2022 · Journal of Clinical Investigation
  48. Prolonged Antiretroviral Therapy Preserves HIV-1-Specific CD8 T Cells with Stem Cell-Like Properties
    Selena Viganó, Jordi Negron, Zhengyu Ouyang, Eric S. Rosenberg, Bruce D. Walker, Mathias D. Lichterfeld, Xu G. Yu · 2015 · Journal of Virology
  49. Programmed death-1 as a factor in immune exhaustion and activation in HIV infection
    DE Kaufmann, Bruce D. Walker · 2008 · Current Opinion in HIV and AIDS
  50. Myd88 Is Required for an Antibody Response to Retroviral Infection
    Edward P. Browne, Dan R. Littman · 2009 · PLoS Pathogens
  51. PD-L1 Blockade Differentially Impacts Regulatory T Cells from HIV-Infected Individuals Depending on Plasma Viremia
    Cristina Peligero, Jordi M. Argilaguet, Robert Güerri‐Fernández, Berta Torres, Carmen Ligero, Pilar Colomer, Montserrat Plana, Hernando Knobel, Felipe García, Andreas Meyerhans · 2015 · PLoS Pathogens
  52. Acute Viral Respiratory Infection Rapidly Induces a CD8+ T Cell Exhaustion–like Phenotype
    John J. Erickson, Lu Wang, Sherry C. Wen, Andrew K. Hastings, Pavlo Gilchuk, Sebastian Joyce, Yu Shyr, John V. Williams · 2015 · The Journal of Immunology
  53. Immune Checkpoint Inhibitors in Melanoma: A Review of Pharmacokinetics and Exposure–Response Relationships
    Cyril Leven, Maël Padelli, Jean‐Luc Carré, Éric Bellissant, L. Misery · 2019 · Clinical Pharmacokinetics
  54. Up-Regulation of Programmed Death-1 Expression on Beryllium-Specific CD4+ T Cells in Chronic Beryllium Disease
    Brent E. Palmer, Douglas G. Mack, Arlan D. Martin, May M. Gillespie, Margaret M. Mroz, Lisa A. Maier, Andrew P. Fontenot · 2008 · The Journal of Immunology
  55. Protective CD8 T Cell Memory Is Impaired during Chronic CD70-Driven Costimulation
    Klaas P. J. M. van Gisbergen, Ronald W. van Olffen, Josine van Beek, Koenraad F. van der Sluijs, Ramon Arens, Martijn A. Nolte, René A. W. van Lier · 2009 · The Journal of Immunology
  56. Upregulation of PD-1 on CD4+CD25+T cells is associated with immunosuppression in liver of mice infected with Echinococcus multilocularis
    Xiaolin La, Fengbo Zhang, Yanhua Li, Jun Li, Yuyuan Guo, Hui Zhao, Nannan Pang, Xiumin Ma, Hao Wen, Haining Fan et al. · 2015 · International Immunopharmacology
  57. Regulatory T Cells in HIV Infection: Can Immunotherapy Regulate the Regulator?
    Mohammad-Ali Jenabian, Petronela Ancuța, Norbert J. Gilmore, Jean‐Pierre Routy · 2012 · Clinical and Developmental Immunology
  58. Cellular and molecular mechanisms of memory T-cell survival
    André Tanel, Simone Gonçalves Fonseca, Bader Yassine‐Diab, Rebeka Bordi, Joumana Zeidan, Yu Shi, Clarisse Benne, Rafick‐Pierre Sékaly · 2009 · Expert Review of Vaccines
  59. Targeted Immune Interventions for an HIV-1 Cure
    Matthieu Perreau, Riddhima Banga, Giuseppe Pantaleo · 2017 · Trends in Molecular Medicine
  60. HIV-Induced Changes in T Cell Signaling Pathways
    Marc Schweneker, David Favre, Jeffrey N. Martin, Steven G. Deeks, J M McCune · 2008 · The Journal of Immunology
  61. Interleukin-21 and cellular activation concurrently induce potent cytotoxic function and promote antiviral activity in human CD8 T cells
    Anita Parmigiani, Maria Pallin, Helena Schmidtmayerova, Mathias Georg Lichtenheld, Savita G. Pahwa · 2010 · Human Immunology
  62. Influence of PD ‐ L 1 cross‐linking on cell death in PD ‐ L 1‐expressing cell lines and bovine lymphocytes
    Ryoyo Ikebuchi, Satoru Konnai, Tomohiro Okagawa, Kazumasa Yokoyama, Chie Nakajima, Yasuhiko Suzuki, Shiro Murata, Kazuhiko Ohashi · 2014 · Immunology
  63. B7-H1 limits the entry of effector CD8+T cells to the memory pool by upregulating Bim
    Rachel Gibbons, Xin Liu, Vesna Pulko, Susan M. Harrington, Christopher J. Krco, Eugene D. Kwon, Haidong Dong · 2012 · OncoImmunology
  64. Therapeutic Blockade of Transforming Growth Factor Beta Fails To Promote Clearance of a Persistent Viral Infection
    Lucile Garidou, Sara Heydari, Selamawit Gossa, Dorian B. McGavern · 2012 · Journal of Virology
  65. B7-DC-Ig Enhances Vaccine Effect by a Novel Mechanism Dependent on PD-1 Expression Level on T Cell Subsets
    Mikayel Mkrtichyan, Yana George Najjar, Estella C. Raulfs, Linda L. Liu, Solomon Langerman, Geoffrey C. Guittard, Laurent L. Ozbun, Samir N. Khleif · 2012 · The Journal of Immunology
  66. Increased B7-H1 Expression on Dendritic Cells Correlates with Programmed Death 1 Expression on T Cells in Simian Immunodeficiency Virus-Infected Macaques and May Contribute to T Cell Dysfunction and Disease Progression
    Huanbin Xu, Xiaolei Wang, Bapi Pahar, Terri Moroney‐Rasmussen, Xavier A. Alvarez, Andrew A. Lackner, Ronald S. Veazey · 2010 · The Journal of Immunology
  67. Reversing Gut Damage in HIV Infection: Using Non-Human Primate Models to Instruct Clinical Research
    Rosalie Ponte, Vikram Mehraj, Peter Ghali, Anne Couëdel-Courteille, Rémi Cheynier, Jean‐Pierre Routy · 2016 · EBioMedicine
  68. Multiparameter Flow Cytometry Monitoring of T Cell Responses
    Holden Terry Maecker · 2009 · Methods in molecular biology
  69. The Use of the Humanized Mouse Model in Gene Therapy and Immunotherapy for HIV and Cancer
    Mayra A. Carrillo, Anjie Zhen, Scott G. Kitchen · 2018 · Frontiers in Immunology
  70. Inhibitory TCR Coreceptor PD-1 Is a Sensitive Indicator of Low-Level Replication of SIV and HIV-1
    Nadine C. Salisch, DE Kaufmann, Amany S. Awad, Roger Keith Reeves, Daniel P. Tighe, Yuan Li, Michael Piatak, Jeffrey D. Lifson, David T. Evans, Florencia Pereyra et al. · 2009 · The Journal of Immunology
  71. Programmed death-1 receptor suppresses γ-IFN producing NKT cells in human tuberculosis
    Amar Ranjan Singh, Aparajit Ballav Dey, Anant Mohan, Dipendra Kumar Mitra · 2014 · Tuberculosis
  72. Regulatory B Cells Inhibit Cytotoxic T Lymphocyte (CTL) Activity and Elimination of Infected CD4 T Cells after In Vitro Reactivation of HIV Latent Reservoirs
    Basile T. Siewe, Jennillee Wallace, Sonya Rygielski, Jack T. Stapleton, Jeffrey N. Martin, Steven G. Deeks, ALAN L. LANDAY · 2014 · PLoS ONE
  73. Programmed Death (PD)-1-Deficient Mice Are Extremely Sensitive to Murine Hepatitis Virus Strain-3 (MHV-3) Infection
    Yongwen Chen, Shengxi Wu, Guoning Guo, Lei Fei, Sheng Jie Guo, Chengying Yang, Xiaolan Fu, Yuzhang Wu · 2011 · PLoS Pathogens
  74. Regulation of T‐cell migration and effector functions: insights from in vivo imaging studies
    Mikaël J. Pittet, Thorsten R. Mempel · 2008 · Immunological Reviews
  75. Non-AIDS-related malignancies: expert consensus review and practical applications from the multidisciplinary CANCERVIH Working Group
    Jean‐Philippe Spano, Isabelle Poizot‐Martin, Dominique G. Costagliola, F. Boué, Olivier Rosmorduc, A. Lavolé, Sylvain Choquet, Pierre‐Etienne Heudel, Véronique Leblond, Jean Gabarre et al. · 2015 · Annals of Oncology
  76. Therapeutic Vaccines for the Treatment of HIV
    Zhilin Chen, Boris Dominik Jülg · 2020 · Translational research
  77. Immune-Checkpoint Blockade Therapy in Lymphoma
    Ayumi Kuzume, SungGi Chi, Nobuhiko Yamauchi, Yosuke Minami · 2020 · International Journal of Molecular Sciences
  78. Updated Insights into the T Cell-Mediated Immune Response against SARS-CoV-2: A Step towards Efficient and Reliable Vaccines
    Manish K. Dhawan, Ali Ahmed Rabaan, Mahmoud M. Fawarah, Souad A. Almuthree, Roua Abdullah Alsubki, Amal H. Alfaraj, Mutaib M. Mashraqi, Saleh Alshamrani, Wesam A. Abduljabbar, Ameen S. S. Alwashmi et al. · 2023 · Vaccines
  79. Functional Unresponsiveness and Replicative Senescence of Myeloid Leukemia Antigen–specific CD8+ T Cells After Allogeneic Stem Cell Transplantation
    Gregory Lawrence Beatty, Jasmine S. Smith, Ran Reshef, Kunal P. Patel, Theresa A. Colligon, Barbara A. Vance, Noelle V. Frey, F Brad Johnson, David L. Porter, Robert H. Vonderheide · 2009 · Clinical Cancer Research
  80. The quest for a T cell-based immune correlate of protection against HIV: a story of trials and errors
    Richard A. Koup, Barney S. Graham, Daniel C. Douek · 2010 · Nature reviews. Immunology
  81. Epigenetic regulation of T cell adaptive immunity
    Adolfo B. Frias, Shannon Kathryn Boi, Xin Lan, Ben Youngblood · 2021 · Immunological Reviews
  82. HIV-1–Host Interaction in Gut-Associated Lymphoid Tissue (GALT): Effects on Local Environment and Comorbidities
    Sonia Moretti, Ivan Schietroma, Giuseppe Sberna, Maria Teresa Maggiorella, Leonardo Sernicola, Stefania Farcomeni, Marta Giovanetti, Massimo Ciccozzi, Alessândra Borsetti · 2023 · International Journal of Molecular Sciences
  83. PD‐1 expression on Melan‐A‐reactive T cells increases during progression to metastatic disease
    Holger Krönig, Kathrin Julia Falchner, Marcus Odendahl, Bettina Brackertz, Heinke Conrad, Dieter Muck, Rüdiger Hein, Christian U. Blank, Christian Peschel, Bernhard Haller et al. · 2011 · International Journal of Cancer
  84. Myeloid-Derived Suppressor Cells Impair Alveolar Macrophages through PD-1 Receptor Ligation during Pneumocystis Pneumonia
    Guang-Sheng Lei, Chen Zhang, Chao‐Hung Lee · 2014 · Infection and Immunity
  85. Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment
    Jennifer A. Juno, Andrew Stalker, Jillian L.M. Waruk, Julius Otieno Oyugi, Makobu Kimani, Francis Allan Plummer, Joshua Kimani, Keith Raymond Fowke · 2015 · Retrovirology
  86. Neurocognitive decline in HIV patients is associated with ongoing T‐cell activation in the cerebrospinal fluid
    Oliver Martin Grauer, Doris Reichelt, Ute Oelker-Grueneberg, Hubertus Lohmann, Tilman Schneider‐Hohendorf, Andreas Schulte‐Mecklenbeck, Catharina C. Groß, Sven Guenther Meuth, Heinz Wiendl, Ingo Wilhelm Husstedt · 2015 · Annals of Clinical and Translational Neurology
  87. CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA
    Genevieve Elizabeth Martin, Matthew J. Pace, John Patrick Thornhill, Chansavath Phetsouphanh, Jodi Meyerowitz, Morgane Gossez, Emily Hopkins, Helen Brown, Nicola Robinson, Natalia J. Olejniczak et al. · 2018 · Frontiers in Immunology
  88. Immune Checkpoints as the Immune System Regulators and Potential Biomarkers in HIV-1 Infection
    Maike Sperk, Robert van Domselaar, Ujjwal Neogi · 2018 · International Journal of Molecular Sciences
  89. Increased PD-1 and decreased CD28 expression in chronic hepatitis B patients with advanced hepatocellular carcinoma
    Ping‐Ning Hsu, Tsuey‐Ching Yang, Jung‐Ta Kao, Ken-Sheng Cheng, Yi-Ju Lee, Yuan-Min Wang, Chin-Tung Hsieh, Cheng‐Wen Lin, Yi‐Ying Wu · 2010 · Liver International
  90. Blockade of Programmed Death-1 in Young (New Zealand Black × New Zealand White)F1 Mice Promotes the Activity of Suppressive CD8+ T Cells That Protect from Lupus-Like Disease
    Maida Wong, Antonio La Cava, Ram Pyare Singh, Bevra Hannahs Hahn · 2010 · The Journal of Immunology
  91. Follicular helper T cell exhaustion induced by PD-L1 expression in hepatocellular carcinoma results in impaired cytokine expression and B cell help, and is associated with advanced tumor stages.
    Zun‐Qiang Zhou, Danian Tong, Jiao Guan, Hung-Wu Tan, Lu-Don Zhao, Ying Zhu, Jing Yao, Jun Yang, Zhengyun Zhang · 2016 · Europe PMC (PubMed Central)
  92. HIV-Specific CD8+T Cells from Elite Controllers Are Primed for Survival
    Jiyu Yan, Steffanie Sabbaj, Anju Bansal, Nilesh Amatya, John J. Shacka, Paul Goepfert, Sonya L. Heath · 2013 · Journal of Virology
  93. Down‐modulation of programmed death 1 alters regulatory T cells and promotes experimental autoimmune encephalomyelitis
    Chunhe Wang, Yuexin Li, Thomas M. Proctor, Arthur A. Vandenbark, Halina Offner · 2009 · Journal of Neuroscience Research
  94. Limited Immunogenicity of HIV CD8+ T-Cell Epitopes in Acute Clade C Virus Infection
    Mopo Radebe, Kriebashnie Nair, Fundisiwe Chonco, Karen Suzanne Bishop, Jaclyn K. Wright, Mary van der Stok, Ingrid Valerie Bassett, Zenele Mncube, Marcus A. Altfeld, Bruce D. Walker et al. · 2011 · The Journal of Infectious Diseases
  95. Reduced Tim-3 Expression on Human T-lymphotropic Virus Type I (HTLV-I) Tax-specific Cytotoxic T Lymphocytes in HTLV-I Infection
    Nashwa H. Abdelbary, Hazem M. Abdullah, Toshio Matsuzaki, Daisuke Hayashi, Yuetsu Tanaka, Hiroshi Takashima, Shuji Izumo, Ryuji Kubota · 2011 · The Journal of Infectious Diseases
  96. Upregulation of Immune Checkpoint Molecules, PD-1 and LAG-3, on CD4+ and CD8+ T Cells after Gastric Cancer Surgery.
    Seigo Takaya, Hiroaki Saito, Masahide Ikeguchi · 2015 · PubMed Central
  97. Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation
    Koichi Araki, Shivaprakash Gangappa, Dirck L. Dillehay, Barry T. Rouse, Christian P. Larsen, Rafi Ahmed · 2010 · The Journal of Experimental Medicine
  98. The Yin and Yang of regulatory T cells in infectious diseases and avenues to target them
    Emmanuel Stephen Victor, Iris Bosschem, Freddy Haesebrouck, Jagadeesh Bayry · 2017 · Cellular Microbiology
  99. Sugar or Fat?—Metabolic Requirements for Immunity to Viral Infections
    Hesham M. Shehata, Andrew James Murphy, Man K.S. Lee, Clair M. Gardiner, Suzanne M. Crowe, Shomyseh Sanjabi, David K. Finlay, Clovis Steve Palmer · 2017 · Frontiers in Immunology
  100. Low Levels of T Cell Exhaustion in Tuberculous Lung Granulomas
    Eileen A. Wong, Louis R. Joslyn, Nicole L. Grant, Edwin C. Klein, Philana Ling Lin, Denise E. Kirschner, JoAnne L. Flynn · 2018 · Infection and Immunity